Industrial natural product chemistry for drug discovery and development
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Industrial natural product chemistry for drug discovery and development
Authors
Keywords
-
Journal
NATURAL PRODUCT REPORTS
Volume 31, Issue 1, Pages 35-60
Publisher
Royal Society of Chemistry (RSC)
Online
2013-10-21
DOI
10.1039/c3np70058e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Continuous-Flow Process for the Synthesis of Artemisinin
- (2013) Daniel Kopetzki et al. CHEMISTRY-A EUROPEAN JOURNAL
- Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects
- (2013) Stephan A. Veltkamp et al. CLINICAL DRUG INVESTIGATION
- High-level semi-synthetic production of the potent antimalarial artemisinin
- (2013) C. J. Paddon et al. NATURE
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Natural Product Synthesis: Changes over Time
- (2012) Reinhard W. Hoffmann ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Merging Chemical Synthesis and Biosynthesis: A New Chapter in the Total Synthesis of Natural Products and Natural Product Libraries
- (2012) Andreas Kirschning et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Continuous-Flow Synthesis of the Anti-Malaria Drug Artemisinin
- (2012) François Lévesque et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Brentuximab Vedotin: A New Age in the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
- (2012) Stephanie S Minich ANNALS OF PHARMACOTHERAPY
- Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies
- (2012) Yang Song et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus
- (2012) Masakazu Imamura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Brentuximab Vedotin
- (2012) C. Deng et al. CLINICAL CANCER RESEARCH
- U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma
- (2012) R. A. de Claro et al. CLINICAL CANCER RESEARCH
- Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
- (2012) Muhammad A. Abdul-Ghani et al. Current Diabetes Reports
- Effects of SGLT2 inhibitors on cardiovascular outcomes
- (2012) Celine Foote et al. Diabetes & Vascular Disease Research
- Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus
- (2012) G. Luippold et al. DIABETES OBESITY & METABOLISM
- The incretin hormones: from scientific discovery to practical therapeutics
- (2012) S. Mudaliar et al. DIABETOLOGIA
- Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agents
- (2012) William N Washburn EXPERT OPINION ON THERAPEUTIC PATENTS
- mTOR kinase inhibitors as a treatment strategy in hematological malignancies
- (2012) Olga Grzybowska-Izydorczyk et al. Future Medicinal Chemistry
- Discovery of Tofogliflozin, a Novel C-Arylglucoside with an O-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
- (2012) Yoshihito Ohtake et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Fingolimod for Multiple Sclerosis
- (2012) Daniel Pelletier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Can New Chemistry Make a Malaria Drug Plentiful and Cheap?
- (2012) K. Kupferschmidt SCIENCE
- Biosynthetic medicinal chemistry of natural product drugs
- (2012) Frank E. Koehn MedChemComm
- Small molecules targeting phosphoinositide 3-kinases
- (2012) Peng Wu et al. MedChemComm
- Drug discovery and development: lessons from an undeveloped drug
- (2012) Toufigh Gordi Expert Review of Clinical Pharmacology
- Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
- (2011) Philippe Aftimos et al. ADVANCES IN THERAPY
- Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
- (2011) S. L. Holt et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Structural selectivity of human SGLT inhibitors
- (2011) Charles S. Hummel et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Insights into the pharmacological relevance of lysophospholipid receptors
- (2011) Tetsuji Mutoh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Artemisinin: Discovery from the Chinese Herbal Garden
- (2011) Louis H. Miller et al. CELL
- Recent advances in the synthesis of new glycopeptide antibiotics
- (2011) Polly-Anna Ashford et al. CHEMICAL SOCIETY REVIEWS
- Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
- (2011) Howard A. Burris et al. Clinical Breast Cancer
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
- (2011) Jens Ingwersen et al. CLINICAL IMMUNOLOGY
- Inhibition of SGLT2: A Novel Strategy for Treatment of Type 2 Diabetes Mellitus
- (2011) M Pfister et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Discovery of Antibacterials and Other Bioactive Compounds from Microorganisms — Evaluating Methodologies for Discovery and Generation of Non-Ribosomal Peptide Antibiotics
- (2011) K. Witting et al. CURRENT DRUG TARGETS
- Present and Future of PI3K Pathway Inhibition in Cancer: Perspectives and Limitations
- (2011) E. Ciraolo et al. CURRENT MEDICINAL CHEMISTRY
- Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
- (2011) S. J. Shuttleworth et al. CURRENT MEDICINAL CHEMISTRY
- ATP-Competitive Inhibitors of mTOR: An Update
- (2011) S. Schenone et al. CURRENT MEDICINAL CHEMISTRY
- The Chemical Biology of Immunophilin Ligands
- (2011) S. Gaali et al. CURRENT MEDICINAL CHEMISTRY
- Natural products as catalysts for innovation: a pharmaceutical industry perspective
- (2011) Esther K Schmitt et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Glycopeptide Antibiotics and their Novel Semi-Synthetic Derivatives
- (2011) Marimuthu Jeya et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The State of the Art in Anti-Malarial Drug Discovery and Development
- (2011) Jeremy N. Burrows et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus
- (2011) Sherwyn L. Schwartz et al. Diabetes Technology & Therapeutics
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- Novel GLP-1 receptor agonists for diabetes
- (2011) Alan J Garber EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
- (2011) Qian Zhou et al. Future Oncology
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
- (2011) Raktim Kumar Ghosh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Targeted Drug Delivery Using Immunoconjugates
- (2011) Maria Valentina Pasquetto et al. JOURNAL OF IMMUNOTHERAPY
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
- (2011) Cherilyn R. Strader et al. JOURNAL OF NATURAL PRODUCTS
- A Redesigned Vancomycin Engineered for Duald-Ala-d-Ala andd-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
- (2011) Jian Xie et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- SGLT2 inhibitors: molecular design and potential differences in effect
- (2011) Masayuki Isaji KIDNEY INTERNATIONAL
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Natural products and Pharma 2011: Strategic changes spur new opportunities
- (2011) Guy T. Carter NATURAL PRODUCT REPORTS
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo
- (2011) Atsuo Tahara et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- A Hydrogen Peroxide Based Access to Qinghaosu (Artemisinin)
- (2011) Hong-Dong Hao et al. ORGANIC LETTERS
- Microbial production of isoprenoids
- (2011) Sunil S. Chandran et al. PROCESS BIOCHEMISTRY
- Methodological advances permit the stereocontrolled construction of diverse fully synthetic tetracyclines containing an all-carbon quaternary center at position C5a
- (2011) Peter M. Wright et al. TETRAHEDRON
- A practical, convergent route to the key precursor to the tetracycline antibiotics
- (2011) David A. Kummer et al. Chemical Science
- PI3K Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic
- (2011) D. A. Fruman et al. Cancer Discovery
- Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus
- (2011) John E Gerich et al. Expert Review of Clinical Pharmacology
- Development and potential role of type-2 sodium-glucose transporter inhibitors for management of type 2 diabetes
- (2011) Timothy Colin Hardman et al. Diabetes Therapy
- Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosis
- (2010) Chang Wook Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics forIn vivoEfficacy under Intermittent Dosing Conditions
- (2010) Murray J. Towle et al. CANCER RESEARCH
- An Expeditious Route to Fluorinated Rapamycin Analogues by Utilising Mutasynthesis
- (2010) Rebecca J. M. Goss et al. CHEMBIOCHEM
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dapagliflozin: more than just another oral glucose-lowering agent?
- (2010) Niki Katsiki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biosynthesis of rapamycin and its regulation: past achievements and recent progress
- (2010) Sung Ryeol Park et al. JOURNAL OF ANTIBIOTICS
- Trastuzumab-DM1: Building a Chemotherapy-Free Road in the Treatment of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2010) Steven J. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of Canagliflozin, a NovelC-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus(1)
- (2010) Sumihiro Nomura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ziconotide for treatment of severe chronic pain
- (2010) Achim Schmidtko et al. LANCET
- Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules
- (2010) M. Lopus et al. MOLECULAR CANCER THERAPEUTICS
- The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao)
- (2010) Geoffrey D. Brown MOLECULES
- Natural product mode of action (MOA) studies: a link between natural and synthetic worlds
- (2010) James J. La Clair NATURAL PRODUCT REPORTS
- Demand for malaria drug soars
- (2010) Richard Van Noorden NATURE
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- Liraglutide
- (2010) Daniel J. Drucker et al. NATURE REVIEWS DRUG DISCOVERY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic engineering of artemisinin biosynthesis in Artemisia annua L.
- (2010) Benye Liu et al. PLANT CELL REPORTS
- A concise stereoselective total synthesis of (+)-artemisinin
- (2010) J.S. Yadav et al. TETRAHEDRON
- The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
- (2010) Brian L. Furman TOXICON
- The Biosynthetic Logic of Polyketide Diversity
- (2009) Christian Hertweck ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Halichondrins and E7389
- (2009) Katrina L. Jackson et al. CHEMICAL REVIEWS
- Total Synthesis of Rapamycin
- (2009) Steven V. Ley et al. CHEMISTRY-A EUROPEAN JOURNAL
- Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide
- (2009) Renate E. van Genugten et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Telavancin
- (2009) Katherine A. Lyseng-Williamson et al. DRUGS
- Dapagliflozin
- (2009) P. Cole et al. DRUGS OF THE FUTURE
- Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective
- (2009) Salvatore Brugaletta et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning
- (2009) Trung H.M. Pham et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2
- (2009) William N. Washburn JOURNAL OF MEDICINAL CHEMISTRY
- New Syntheses of E7389 C14−C35 and Halichondrin C14−C38 Building Blocks: Reductive Cyclization and Oxy-Michael Cyclization Approaches
- (2009) Cheng-Guo Dong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Discovery of Artemisinin (Qinghaosu)
- (2009) Fulong Liao MOLECULES
- Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs
- (2009) Edmund I. Graziani NATURAL PRODUCT REPORTS
- Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
- (2009) Carmen Cuevas et al. NATURAL PRODUCT REPORTS
- Conotoxins: natural product drug leads
- (2009) Reena Halai et al. NATURAL PRODUCT REPORTS
- Flexible tetracycline synthesis yields promising antibiotics
- (2009) Martin D Burke Nature Chemical Biology
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
- (2009) Florian Mullershausen et al. Nature Chemical Biology
- Everolimus
- (2009) Michael B. Atkins et al. NATURE REVIEWS DRUG DISCOVERY
- Telavancin
- (2009) G. Ralph Corey et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of mTOR-mediated translational control
- (2009) Xiaoju Max Ma et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
- (2009) Michael T Guskey et al. PHARMACOTHERAPY
- High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli
- (2009) Hiroko Tsuruta et al. PLoS One
- Intravenous Temsirolimus in Cancer Patients: Clinical Pharmacology and Dosing Considerations
- (2009) Joseph P. Boni et al. SEMINARS IN ONCOLOGY
- Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
- (2009) James J. Gibbons et al. SEMINARS IN ONCOLOGY
- From nature to the laboratory and into the clinic
- (2008) K.C. Nicolaou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel echinocandin antifungals. Part 1: Novel side-chain analogs of the natural product FR901379
- (2008) Masaki Tomishima et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin
- (2008) Masaki Tomishima et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2
- (2008) Bruce A. Ellsworth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Options for the Treatment of Patients with Taxane-Refractory Metastatic Breast Cancer
- (2008) Beth Overmoyer Clinical Breast Cancer
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- The chemistry and biology of the maytansinoid antitumor agents
- (2008) Andreas Kirschning et al. COMPTES RENDUS CHIMIE
- New agents in development for the treatment of bacterial infections
- (2008) D ABBANAT et al. CURRENT OPINION IN PHARMACOLOGY
- Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors†
- (2008) Ming-Qiang Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
- (2008) Wei Meng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
- (2008) Sung Joon Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- A Robust Platform for the Synthesis of New Tetracycline Antibiotics
- (2008) Cuixiang Sun et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Natural products to drugs: natural product-derived compounds in clinical trials
- (2008) Mark S. Butler NATURAL PRODUCT REPORTS
- Drug development from marine natural products
- (2008) Tadeusz F. Molinski et al. NATURE REVIEWS DRUG DISCOVERY
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
- Making artemisinin☆
- (2008) Patrick S. Covello PHYTOCHEMISTRY
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
- Mutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products
- (2007) Jonathan Kennedy NATURAL PRODUCT REPORTS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now